Results 11 to 20 of about 7,389 (213)

Postoperative cystoid macular oedema in a patient on fingolimod. [PDF]

open access: yesBMJ Case Rep, 2015
We describe the first case of fingolimod-associated bilateral cystoid macular oedema (CMO) following uncomplicated cataract surgery. A 57-year-old woman has been on fingolimod for the past 2 years for the treatment of relapsing–remitting multiple sclerosis. She underwent uneventful consecutive cataract surgery 2 weeks apart.
Gaskin JC, Coote M.
europepmc   +4 more sources

Intravitreal dexamethasone implant therapy for the treatment of cystoid macular Oedema due to hydroxychloroquine retinopathy: a case report and literature review [PDF]

open access: yesBMC Ophthalmology, 2018
Background Cystoid macular oedema (CMO) is an uncommon complication associated with hydroxychloroquine (HCQ) retinopathy threatening central vision. We report a patient with HCQ retinopathy and CMO, for which an intravitreal dexamethasone implant was ...
Seong Joon Ahn   +3 more
doaj   +2 more sources

Cystoid macular oedema in Cogans syndrome-a case report [PDF]

open access: yesCases Journal, 2008
Abstract Introduction Cogan's Syndrome is typically characterised by a non syphilitic interstitial keratitis (IK), with or without conjunctivitis, iritis or subconjunctival bleeding and progressive sensorineural hearing loss within two years of ocular signs.
Pherwani, Anupama   +3 more
core   +4 more sources

Retinitis pigmentosa-associated cystoid macular oedema: pathogenesis and avenues of intervention. [PDF]

open access: yesBr J Ophthalmol, 2017
Hereditary retinal diseases are now the leading cause of blindness certification in the working age population (age 16-64 years) in England and Wales, of which retinitis pigmentosa (RP) is the most common disorder.
Strong S, Liew G, Michaelides M.
europepmc   +3 more sources

Intravitreal Fluocinolone Acetonide (ILUVIEN) Implant for the Treatment of Refractory Cystoid Macular Oedema After Retinal Detachment Repair [PDF]

open access: yesTürk Oftalmoloji Dergisi, 2018
Cystoid macular oedema (CMO) is one of the most frequent postoperative macular complications to cause partial visual recovery after successful retinal detachment (RD) repair.
Fadi Alfaqawi   +4 more
doaj   +2 more sources

Cystoid macular oedema

open access: yesIndian Journal of Ophthalmology, 1984
Natarajan Mathivanan   +2 more
doaj   +2 more sources

Cystoid macular oedema

open access: yesIndian Journal of Ophthalmology, 1983
Singh Daljit
doaj   +2 more sources

Intravitreal triamcinolone for the treatment of cystoid macular oedema

open access: yesZdravniški Vestnik, 2005
Background: Longstanding cystoid macular oedema (CME) can result in loss of central vision, and there are only limited therapeutic possibilities. The aim of this article is to report clinical outcome of our patients with CME treated with intravitreal ...
Aleksandra Kraut
doaj   +1 more source

Cystoid macular oedema in aphakic patients

open access: yesIndian Journal of Ophthalmology, 1983
Shah Saroj, Trivedi N, Khamar B
doaj   +2 more sources

An Experience with Intravitreal Dexamethasone Implant for Uveitic Macular Oedema

open access: yesJournal of Nepal Health Research Council, 2021
Intravitreal steroid implants are the latest trend for uveitis macular oedema treatment. Dexamethasone intravitreal implants are new in our contexts but we report 2 cases of uveitic cystoid macular oedema where this implant proved very useful in the ...
Ranju Kharel (Sitaula)   +1 more
doaj   +1 more source

Home - About - Disclaimer - Privacy